We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tandem Diabetes Care Inc | NASDAQ:TNDM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.16 | 2.45% | 48.4599 | 48.45 | 48.46 | 48.40 | 47.08 | 47.68 | 1,234,529 | 00:57:34 |
1. Name and Address of Reporting Person * BERGER DAVID B | 2. Issuer Name and Ticker or Trading Symbol TANDEM DIABETES CARE INC [ TNDM ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Chief Business/Compliance |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 5/27/2021 | M | 1626 | A | $0 | 6488 | D | |||
Common Stock | 5/27/2021 | F(1) | 681 | D | $85.65 | 5807 | D | |||
Common Stock | 5/28/2021 | M(2) | 1854 | A | $9 | 7661 | D | |||
Common Stock | 5/28/2021 | S | 1854 | D | $86.45 | 5807 | D | |||
Common Stock | 5/28/2021 | S | 1765 | D | $86.49 | 4042 | D | |||
Common Stock | 242 | I | Berger Family Trust (3) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Restricted Stock Unit (4) | (5) | 5/27/2021 | M (6) | 1626 | (7) | (7) | Common Stock | 1626.0 | $0 | 4878 | D | ||||
Stock Option | $9.0 | 5/28/2021 | M | 1854 | (8) | (9) | Common Stock | 1854.0 | $0 | 0 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
BERGER DAVID B C/O TANDEM DIABETES CARE, INC. 11075 ROSELLE STREET SAN DIEGO, CA 92121 | EVP, Chief Business/Compliance |
Signatures | ||
s/ Karrie Rexford, Attorney-in-Fact for David B. Berger | 6/1/2021 | |
**Signature of Reporting Person | Date |
1 Year Tandem Diabetes Care Chart |
1 Month Tandem Diabetes Care Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions